Hyperthermia Cancer Treatment Market is estimated to be valued at USD 210.5 Mn in 2025 and is expected to reach USD 318.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 210.5 Mn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
6.10%
2032 Value Projection:
USD 318.6 Mn
Hyperthermia cancer treatment is a novel therapeutic approach that utilizes heat to treat cancer cells. It involves raising the temperature of cancerous cells, either from external sources or by directing heat specifically to the tumor site. Hyperthermia can be used in conjunction with other cancer treatments like chemotherapy and radiation therapy to improve their efficacy.
By subjecting malignant cells to higher temperatures, hyperthermia treatment aims to kill cancer cells, enhance the effectiveness of radiation therapy, and increase the uptake of chemotherapeutic agents. It is a non-invasive method that is gaining momentum in the field of oncology due to its potential to improve patient outcomes and minimize side effects compared to traditional treatments.
Market Dynamics:
The global hyperthermia cancer treatment market is expected to experience significant growth during the forecast period. The market dynamics driving this growth include various factors such as the rising prevalence of cancer worldwide, increasing adoption of innovative cancer treatment methods, and advancements in technology.
Rising cases of cancer globally is one of the key drivers of the Hyperthermia cancer treatment market. According to the data published by the International Agency for Research on Cancer in May 2021, an estimated 19.3 million new cancer cases occurred in 2020. This growing incidence of cancer is expected to fuel demand for effective treatment options, including hyperthermia therapy.
Moreover, technological advancements in hyperthermia treatment devices are expected to propel market growth. The development of advanced heating techniques, such as regional and whole-body hyperthermia, has improved treatment outcomes and expanded the applicability of hyperthermia therapy. Additionally, the integration of hyperthermia devices with imaging modalities allows for real-time temperature monitoring and precise targeting of tumor cells, further enhancing treatment efficacy.
While the market holds immense potential, certain factors may restrain its growth. Limited awareness about hyperthermia treatment among healthcare professionals and patients, high treatment costs, and reimbursement challenges are some of the obstacles that may hinder market expansion. However, efforts to increase awareness, favorable reimbursement policies, and ongoing research and development activities are expected to overcome these challenges.
Key Features of the Study:
This report provides in-depth analysis of the global hyperthermia cancer treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR, %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
Key companies covered as a part of this study include MagForce AG, Andromedic S.r.l., Celsius42 GmbH, Oncotherm Kft, Pyrexar Medical, YAMAMOTO VINITA CO.,LTD, Nanoprobes, Alba Hyperthermia System, Novavida, and Sensius.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgradation, market expansion, and marketing tactics.
The global hyperthermia cancer treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hyperthermia cancer treatment market
Hyperthermia Cancer Treatment Market Detailed Segmentation:
By Treatment Type:
Local Hyperthermia
Regional Hyperthermia
Whole Body Hyperthermia
By Application:
Prostate Cancer
Breast Cancer
Cervical Cancer
Skin Cancer
Other Cancers
By End User:
Hospitals
Clinic
Specialty Centres
Others (Academic and Research Institute)
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Company Profiles
MagForce AG
Andromedic S.r.l.
Celsius42 GmbH
Oncotherm Kft
Pyrexar Medical
YAMAMOTO VINITA CO.,LTD
Nanoprobes
Alba Hyperthermia System
Novavida
Sensius
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Hyperthermia Cancer Treatment Market, By Treatment Type
Global Hyperthermia Cancer Treatment Market, By Application
Global Hyperthermia Cancer Treatment Market, By End User
Global Hyperthermia Cancer Treatment Market, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing prevalence of cancer worldwide
Restraints
High costs of hyperthermia systems
Opportunities
Growing popularity of nanoparticle-mediated hyperthermia
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
4. Hyperthermia Cancer Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Hyperthermia Cancer Treatment Market , By Treatment Type, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Local Hyperthermia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Regional Hyperthermia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Whole Body Hyperthermia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
6. Hyperthermia Cancer Treatment Market, By Application, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Prostate Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Breast Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cervical Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Skin Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Other Cancers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
7. Hyperthermia Cancer Treatment Market, By End User, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Clinic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Specialty Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Academic and Research Institute)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
8. Hyperthermia Cancer Treatment Market, By Region, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, By Country, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Country 2021-2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Mn)